← Leaderboards
Philip J Norris
Massachusetts General Hospital
$6,078,592
Attributed
$6,078,592
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.2M · FY2009–25$2.5M$1.9M$1.3M$625K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,078,592 · 5
By mechanism
N01$2,473,584 · 1
R01$2,309,081 · 1
R21$697,825 · 2
K08$598,102 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Joren C Madsen$70,026,219
- David J Kuter$4,427,404
- John J Iacomini$17,784,530
- James F Markmann$21,074,268
- Bernard Khor$4,267,406
Others in their field
Top investigators on “Cytokine”
- Sharon L Hillier · Magee-Women'S Hospital Of Upmc$83,965,880
- David Heimbrook · Leidos Biomedical Research, Inc.$56,453,265
- Fulton T Crews · University Of North Carolina Chapel Hill$36,249,590
- Marianne Ward · Duke University$34,872,957
- Joren C Madsen · Massachusetts General Hospital$33,058,731
- Barton F Haynes · Duke University$29,068,807
Research focus
CytokineClinical ResearchBloodLinkTransfusionBlood TransfusionResponseCellsNeutrophilLifeLeadImmuneBlood PlateletsLeukocytesImmune ResponseHuman Immunodeficiency Virus 1Human SubjectHiv InfectionsMhc Class Ii AntigenEventCellular ImmunityEpitope MappingHelper T LymphocyteClone Cells
Grant awards (15)
Defining Drivers of mtDNA Levels in Blood Components and Their Impact on Transfusion-Related Lung Injury$262,500
R21 · FY2025 · HL · contact PI
REDS-IV-P CENTER FOR TRANSFUSION LABORATORY STUDIES$2,160,438
N01 · FY2024 · HL · contact PI
REDS-IV-P CENTER FOR TRANSFUSION LABORATORY STUDIES (CTLS) PHASE 2$313,146
N01 · FY2021 · HL · contact PI
Validating the link between NXPH2 and alloimmunization$197,875
R21 · FY2016 · HL · contact PI
Validating the link between NXPH2 and alloimmunization$237,450
R21 · FY2015 · HL · contact PI
Properties of stored RBCs: minimization of immune and vascular reactivity$535,218
R01 · FY2012 · HL · contact PI
Properties of stored RBCs: minimization of immune and vascular reactivity$573,413
R01 · FY2011 · HL · contact PI
Properties of stored RBCs: minimization of immune and vascular reactivity$576,229
R01 · FY2010 · HL · contact PI
Properties of stored RBCs: minimization of immune and vascular reactivity$624,221
R01 · FY2009 · HL · contact PI
CHARACTERIZATION OF HIV-1-SPECIFIC T HELPER CELL CLONES$121,554
K08 · FY2004 · AI
CHARACTERIZATION OF HIV-1-SPECIFIC T HELPER CELL CLONES$89,074
K08 · FY2003 · AI
CHARACTERIZATION OF HIV-1-SPECIFIC T HELPER CELL CLONES$35,421
K08 · FY2003 · AI
CHARACTERIZATION OF HIV-1-SPECIFIC T HELPER CELL CLONES$124,551
K08 · FY2002 · AI
CHARACTERIZATION OF HIV-1-SPECIFIC T HELPER CELL CLONES$113,751
K08 · FY2001 · AI
CHARACTERIZATION OF HIV-1-SPECIFIC T HELPER CELL CLONES$113,751
K08 · FY2000 · AI